EntryPoint Capital LLC Makes New Investment in HealthEquity, Inc. (NASDAQ:HQY)

EntryPoint Capital LLC purchased a new position in shares of HealthEquity, Inc. (NASDAQ:HQY) during the fourth quarter, HoldingsChannel reports. The institutional investor purchased 6,158 shares of the company’s stock, valued at approximately $591,000.

Other hedge funds have also made changes to their positions in the company. Intech Investment Management LLC lifted its position in HealthEquity by 59.5% during the third quarter. Intech Investment Management LLC now owns 21,064 shares of the company’s stock worth $1,724,000 after buying an additional 7,859 shares during the period. Massachusetts Financial Services Co. MA lifted its holdings in shares of HealthEquity by 7.4% during the 3rd quarter. Massachusetts Financial Services Co. MA now owns 484,782 shares of the company’s stock worth $39,679,000 after acquiring an additional 33,523 shares during the period. Charles Schwab Investment Management Inc. boosted its position in shares of HealthEquity by 1.4% in the third quarter. Charles Schwab Investment Management Inc. now owns 1,061,807 shares of the company’s stock worth $86,909,000 after acquiring an additional 14,532 shares during the last quarter. Raymond James Trust N.A. grew its holdings in HealthEquity by 4.8% in the third quarter. Raymond James Trust N.A. now owns 2,905 shares of the company’s stock valued at $238,000 after purchasing an additional 132 shares during the period. Finally, Citigroup Inc. increased its position in HealthEquity by 73.0% during the third quarter. Citigroup Inc. now owns 102,107 shares of the company’s stock worth $8,357,000 after purchasing an additional 43,084 shares during the last quarter. Institutional investors and hedge funds own 99.55% of the company’s stock.

Analysts Set New Price Targets

HQY has been the topic of a number of research analyst reports. Wells Fargo & Company lifted their price target on shares of HealthEquity from $110.00 to $125.00 and gave the company an “overweight” rating in a report on Wednesday, February 26th. JMP Securities upped their price target on HealthEquity from $105.00 to $107.00 and gave the stock a “market outperform” rating in a research note on Tuesday, December 10th. Raymond James lifted their price objective on HealthEquity from $105.00 to $120.00 and gave the company an “outperform” rating in a research note on Tuesday, February 25th. Barrington Research reissued an “outperform” rating and set a $112.00 target price on shares of HealthEquity in a research report on Friday, March 14th. Finally, Mizuho started coverage on shares of HealthEquity in a research report on Wednesday, December 4th. They set an “outperform” rating and a $126.00 price target on the stock. One analyst has rated the stock with a hold rating and twelve have given a buy rating to the stock. Based on data from MarketBeat.com, HealthEquity presently has an average rating of “Moderate Buy” and a consensus price target of $113.69.

HealthEquity Stock Performance

Shares of HQY stock opened at $90.32 on Tuesday. The company has a debt-to-equity ratio of 0.51, a current ratio of 3.20 and a quick ratio of 3.20. The company’s fifty day moving average price is $104.67 and its two-hundred day moving average price is $95.84. The firm has a market capitalization of $7.81 billion, a P/E ratio of 82.86, a P/E/G ratio of 1.60 and a beta of 0.62. HealthEquity, Inc. has a 12 month low of $65.01 and a 12 month high of $115.59.

Insider Transactions at HealthEquity

In related news, Director Robert W. Selander sold 5,750 shares of HealthEquity stock in a transaction on Monday, February 10th. The shares were sold at an average price of $111.29, for a total value of $639,917.50. Following the completion of the sale, the director now owns 78,219 shares in the company, valued at approximately $8,704,992.51. The trade was a 6.85 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 2.20% of the company’s stock.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.